@article{2955239,
    title = "An open-label, randomised phase 3 study of daratumumab, lenalidomide, and dexamethasone (DRd) versus lenalidomide and dexamethasone (Rd) in relapsed or refractory multiple myeloma (RRMM): POLLUX",
    author = "Dimopoulos, M and Oriol, A and Nahi, H and San Miguel, J and Bahlis, N and Rabin, N and Orlowski, R and Komarnicki, M and Suzuki, K and Plesner, T and others",
    journal = "Haematologica-the hematology journal",
    year = "2016",
    volume = "101",
    number = "Suppl 1",
    pages = "342"
}